EU explores legal avenues amid AstraZeneca vaccine dispute

Officials in Brussels have quarrelled with AstraZeneca after the pharmaceutical company said it would deliver smaller than expected supplies to the 27 EU nations.

The AstraZeneca office building in Brussels (Mark Carlson/AP)

The European Union is looking at legal means to guarantee the delivery of all the Covid-19 vaccine doses it bought from AstraZeneca and other pharmaceutical companies.

The European Medicines Agency (EMA) is expected on Friday to authorise use of the vaccine that the Anglo-Swedish company developed with Oxford University.